小儿白血病是小儿发病率最高的恶性肿瘤,最常见的类型为急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL),占所有小儿急性白血病的80%.目前治疗小儿ALL的主要方法是化学药物治疗和造血干细胞移植.
基于10个网页-相关网页
系急性淋巴细胞性白血病(all)为出现于儿童与青少年的最常见的癌症。
B-lineage acute lymphoblastic leukemia (ALL) is the most common cancer occurring in children and adolescents.
目的：为提高急性非淋巴细胞性白血病(急非淋)的疗效。
Objective To improve the therapeutic effect of acute non-lymphatic leukemia (ANLL).
简称“急淋”急性淋巴细胞白血病为起源于造血系统干细胞的克隆性恶性疾病。
Referred to as "ALL", acute lymphoblastic leukemia for the origin of stem cells in the hematopoietic system of clonal malignant disease.
应用推荐